Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Medicare alternative to spiriva?Does fluticasone propionate expire?Cuvitru clinical trials?Ramelteon cost without insurance?Ramelteon brand name?
See the DrugPatentWatch profile for fasenra
Fasenra (benralizumab) was approved in the United States in 2017.[1]
Fasenra’s FDA approval was for severe eosinophilic asthma. The approval is specifically tied to use in patients with this type of asthma.[1]
DrugPatentWatch.com tracks key product and regulatory milestone information, which can help confirm dates like initial approval.[1]
[1] https://www.drugpatentwatch.com/monograph/fasenra-benralizumab
Other Questions About Fasenra :